EQL Pharma AB publ announced earnings results for the third quarter ended December 31, 2019. For the third quarter, the company announced sales was SEK 20.939 million compared to SEK 11.426 million a year ago. Net income was SEK 1.469 million compared to net loss of SEK 1.817 million a year ago. For the nine months, sales was SEK 53.266 million compared to SEK 35.341 million a year ago. Net income was SEK 2.545 million compared to net loss of SEK 480,000 a year ago.